MMP-13 is one of the critical mediators of the effect of HDAC4 deletion on the skeleton
Abstract
No abstract availableKeywords
Funding Information
- NIH (DK47420)
This publication has 36 references indexed in Scilit:
- Targeted deletion of Sost distal enhancer increases bone formation and bone massProceedings of the National Academy of Sciences, 2012
- MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastasesBreast Cancer Research, 2011
- Matrix Metalloproteinase (MMP)-13 Regulates Mammary Tumor–Induced Osteolysis by Activating MMP9 and Transforming Growth Factor-β Signaling at the Tumor-Bone InterfaceCancer Research, 2010
- HDAC4 Represses Matrix Metalloproteinase-13 Transcription in Osteoblastic Cells, and Parathyroid Hormone Controls This RepressionJournal of Biological Chemistry, 2010
- The many roles of histone deacetylases in development and physiology: implications for disease and therapyNature Reviews Genetics, 2009
- Bone quality: the material and structural basis of bone strengthJournal of Bone and Mineral Metabolism, 2008
- Control of the SOST Bone Enhancer by PTH Using MEF2 Transcription FactorsJournal of Bone and Mineral Research, 2007
- Role of Matrix Metalloproteinase 13 in Both Endochondral and Intramembranous Ossification during Skeletal RegenerationPLOS ONE, 2007
- Matrix metalloproteinase-13 influences ERK signalling in articular rabbit chondrocytesOsteoarthritis and Cartilage, 2006
- The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis.Journal of Clinical Investigation, 1996